Where does Praxis Precision Medicines, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Praxis Precision Medicines, Inc. ranks #11,044 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Praxis Precision Medicines, Inc. hold?

Praxis Precision Medicines, Inc. holds 28 US utility patents granted between 2020 and 2025, spanning 9 technology areas.

What is Praxis Precision Medicines, Inc.'s Innovation Score?

Praxis Precision Medicines, Inc. has an Innovation Score of 53.9 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Praxis Precision Medicines, Inc. focus on?

Praxis Precision Medicines, Inc.'s top technology area is C07D (Heterocyclic Compounds) with 22 patents, ranking #404 of 3,165 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Praxis Precision Medicines, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Praxis Precision Medicines, Inc..

What does claim depth mean for Praxis Precision Medicines, Inc.'s patents?

Praxis Precision Medicines, Inc.'s patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Praxis Precision Medicines, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Praxis Precision Medicines, Inc.

USPTO PatentsView assignee record - 28 granted patents across 9 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Praxis ranks #11,044 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 9 technology areas.

#11,044
of 49,997 US assignees by volume: Top 8%
by Innovation Score (53.9/100): 19.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R11044 · US Corporation #11,044 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 28 grants
UPPER-Q #11,044/49,997
PHOTO-FINISH Open Text GXS ULC
CPC-NARROW C07D · 9 areas
INNOV-PAR 53.9/100
CLAIMS-RICH 19.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Open Text GXS ULC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Praxis’s 53.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (22%) Velocity 20.0 pts (37%) Breadth 10.6 pts (20%) Claim depth 11.6 pts (22%)

Qualcomm Incorporated · highest

85
H LEE Moffitt… · near

54
Marvell Israel (M I… · near

54
Praxis Precision… · this assignee

54
Solo Brands · near

54
Sorin CRM SAS · near

54
3D Lighting… · lowest

7

What this shows Praxis's Innovation Score is 53.9/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Praxis?

Each dot is one of Praxis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Praxis’s own 19.4 claims/patent is ABOVE the 14.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Praxis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Praxis's grants concentrate

Praxis Precision Medicines, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 78.6% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2023 (9 grants) versus a trough of 1 in 2020. By volume, Praxis sits between Open Text GXS ULC and Pie Medical Imaging B.V..

Praxis's three-year grant acceleration

Praxis Precision Medicines, Inc. shows 21 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Open Text GXS ULC

28
PCT International

28
Permobil AB

28
Phihong Technology

28
Prolific Technolo…

28
PSK

28
Panzura

28
Pie Medical Imagi…

28
Praxis Precision… ◀

28

What this shows Praxis holds 28 patents at rank #11,038, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Praxis

By rank, the assignees closest to #11,038 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Praxis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Praxis, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Praxis ranks #404 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Solo Brands, LLC 54 Sorin CRM SAS 54 H. LEE Moffitt Cancer Center AND Research Institute Inc. 54 Marvell Israel (M.I.S.L) Ltd. 54

Praxis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Praxis Precision Medicines, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	3.6%
2021	2	7.1%
2022	6	21.4%
2023	9	32.1%
2024	6	21.4%
2025partial year	4	14.3%

Which technologies does Praxis Precision Medicines, Inc. patent most?

C07D - Heterocyclic Compounds 22

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 19

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 19

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 12

C07J - Steroids 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C07K - Peptides 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Praxis Precision Medicines, Inc.'s patent record in context - here's where to go next.

Praxis Precision Medicines, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 78.6% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #11,044 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Praxis Precision Medicines, Inc. against Open Text GXS ULC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.